A new market study, titled “Global 3D Bioprinting for Life Science R&D Market Size, Status and Forecast 2018-2025” has been featured on WiseGuyReports.
This report focuses on the global 3D Bioprinting for Life Science R&D market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the 3D Bioprinting for Life Science R&D development in United States, Europe and China.
3D printing first got widespread public attention in 2013, when it was specifically mentioned by President Obama in his State of the Union Address. 3D printing is a manufacturing process where an object is created with the help of a layer-by-layer material approach. Each layer can be considered a thin horizontal cross-section of the final product. It uses Computer Aided Design (CAD) i.e. a digital blueprint to create rapid prototypes, spare parts and final products. 3D printing uses materials like thermoplastics, plastic composites, metals, alloys, ceramics etc. 3D printing as an end-use manufacturing technology is still not fully developed but it has the potential to transform the conception, manufacturing and logistics processes.
The drug testing market is likely to be the main driver of the 3D Bioprinting for Life Science R&D Market. Since 2011, a group of U.S. government agencies have been investing in something known as ‘Human on a chip’ or ‘Body on a chip’. The objective is to create a miniature human organ system that mimics the bodily response to harmful agents, enabling the development of potential therapies. The pharmaceutical industry could use such equipment to test drugs more efficiently due to human stem cells and at a much lower cost. It would also be less risky.
The second 3D Bioprinting for Life Science R&D Market driver could be patients wanting to print personalised medicine at home which matches their genetic profile or medical history. This may well be one of the most profound business transformations in the pharmaceutical industry. While it is still in the early stages, the cost advantages and the quality outcome could be massive indeed.
The key players covered in this study
EnvisionTEC
Regenovo
Organovo
3D Systems
3D Biotek
Advanced Biomatrix
Digilab
Nano3D Biosciences
Request Sample Report at https://www.wiseguyreports.com/sample-request/3357274-global-3d-bioprinting-for-life-science-r-d
Market segment by Type, the product can be split into
Magnetic 3D Bioprinting
Laser-Assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Market segment by Application, split into
Clinical
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global 3D Bioprinting for Life Science R&D status, future forecast, growth opportunity, key market and key players.
To present the 3D Bioprinting for Life Science R&D development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of 3D Bioprinting for Life Science R&D are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2018-2025
14 Analyst’s Viewpoints/Conclusions
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
